A retrospective, cohort study analyzing efficacy of immunotherapy in metastatic ocular melanoma
Latest Information Update: 07 Jul 2022
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Uveal melanoma
- Focus Therapeutic Use
Most Recent Events
- 07 Jul 2022 New Trial Record
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology